PL337201A1 - Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione - Google Patents

Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione

Info

Publication number
PL337201A1
PL337201A1 PL98337201A PL33720198A PL337201A1 PL 337201 A1 PL337201 A1 PL 337201A1 PL 98337201 A PL98337201 A PL 98337201A PL 33720198 A PL33720198 A PL 33720198A PL 337201 A1 PL337201 A1 PL 337201A1
Authority
PL
Poland
Prior art keywords
triazinolydino
dione
pyridyl
benzyl
methyl
Prior art date
Application number
PL98337201A
Other languages
English (en)
Inventor
Jai Patel
Hamish Ross
Jeffrey Roger Granett
Robin Price
Paul Nigel Wray
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of PL337201A1 publication Critical patent/PL337201A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL98337201A 1997-06-05 1998-06-02 Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione PL337201A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition

Publications (1)

Publication Number Publication Date
PL337201A1 true PL337201A1 (en) 2000-08-14

Family

ID=26311662

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337201A PL337201A1 (en) 1997-06-05 1998-06-02 Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione

Country Status (29)

Country Link
EP (1) EP0998284A1 (fr)
JP (1) JP2001521553A (fr)
KR (1) KR20010013410A (fr)
CN (3) CN1112926C (fr)
AP (1) AP1214A (fr)
AR (2) AR015120A1 (fr)
AU (1) AU8215098A (fr)
BG (1) BG104048A (fr)
BR (1) BR9810405A (fr)
CA (2) CA2333352A1 (fr)
CO (1) CO4940400A1 (fr)
DZ (1) DZ2510A1 (fr)
EA (1) EA002384B1 (fr)
GB (1) GB9711683D0 (fr)
HU (1) HUP0004070A3 (fr)
ID (1) ID24264A (fr)
IL (1) IL133074A0 (fr)
MX (1) MXPA99011322A (fr)
NO (2) NO995938L (fr)
NZ (2) NZ523725A (fr)
OA (1) OA11306A (fr)
PE (1) PE78899A1 (fr)
PL (1) PL337201A1 (fr)
SK (1) SK164899A3 (fr)
TR (2) TR200002790T2 (fr)
TW (1) TW570797B (fr)
UY (1) UY25032A1 (fr)
WO (1) WO1998055122A1 (fr)
ZA (2) ZA984826B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
EP1903043A1 (fr) 1999-04-23 2008-03-26 SmithKline Beecham P.L.C. Nouveau composé pharmaceutique
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003050112A1 (fr) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Hydrates de toluenesulfonate d'un derive de thiazolidinedione
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
EP2270007A1 (fr) * 2006-05-09 2011-01-05 Teva Pharmaceutical Industries Ltd. Acide 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioique, procédés de préparation et compositions avec le maléate de rosiglitazone
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (fr) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Composés hétécycliques bicycliques utilisés en tant que modulateurs des ror-gamma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
CA2182986A1 (fr) * 1994-02-10 1995-08-17 Smithkline Beecham P.L.C. Utilisation de sensibilisateurs a l'insuline dans le traitement de l'insuffisance renale
EA199800177A1 (ru) * 1995-08-10 1998-10-29 Варнер-Ламберт Компани Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
WO1997018811A1 (fr) * 1995-11-17 1997-05-29 Warner-Lambert Company Procede de traitement de dystrophie myotonique
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
CA2260044A1 (fr) * 1996-07-12 1998-01-22 Stephen Alistair Smith Nouveau traitement contre la resistance a la leptine

Also Published As

Publication number Publication date
WO1998055122A1 (fr) 1998-12-10
AU8215098A (en) 1998-12-21
IL133074A0 (en) 2001-03-19
CA2333352A1 (fr) 1998-12-10
CA2292629A1 (fr) 1998-12-10
AP9901696A0 (en) 1999-12-31
ID24264A (id) 2000-07-13
NO20040738L (no) 2000-02-02
NO995938L (no) 2000-02-02
TW570797B (en) 2004-01-11
NZ513922A (en) 2001-09-28
DZ2510A1 (fr) 2003-01-25
ZA9811572B (en) 1999-07-22
JP2001521553A (ja) 2001-11-06
AR008198A1 (es) 1999-12-29
EA199901116A1 (ru) 2000-06-26
UY25032A1 (es) 1998-11-26
NO995938D0 (no) 1999-12-03
CO4940400A1 (es) 2000-07-24
CN1526391A (zh) 2004-09-08
EP0998284A1 (fr) 2000-05-10
CN1430959A (zh) 2003-07-23
BG104048A (bg) 2000-07-31
CN1259050A (zh) 2000-07-05
CN1112926C (zh) 2003-07-02
ZA984826B (en) 1999-08-03
BR9810405A (pt) 2000-08-29
AP1214A (en) 2003-10-08
EA002384B1 (ru) 2002-04-25
PE78899A1 (es) 1999-10-22
CA2292629C (fr) 2004-01-06
AR015120A1 (es) 2001-04-18
TR199902963T2 (xx) 2000-02-21
SK164899A3 (en) 2000-11-07
HUP0004070A2 (hu) 2002-02-28
MXPA99011322A (es) 2004-12-02
TR200002790T2 (tr) 2001-11-21
NZ523725A (en) 2004-09-24
KR20010013410A (fr) 2001-02-26
HUP0004070A3 (en) 2002-03-28
OA11306A (en) 2003-10-22
GB9711683D0 (en) 1997-08-06

Similar Documents

Publication Publication Date Title
WO2000017190A3 (fr) Derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
PL337201A1 (en) Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione
AU8441798A (en) Tricyclically substituted oxazolidinones
PL341146A1 (en) Maleic 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolydin-2,4-dione salt hydrate as a pharmacological agent
AUPP003197A0 (en) New heterocyclic compounds
IL146111A0 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
AU7907498A (en) Novel heterocyclic compounds
IL155036A0 (en) Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
PL341147A1 (en) Maleic 5-[4-[2[(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl}thiazolydin-2,4-dione salt hydrate
NO2009002I1 (no) 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid
AU7907298A (en) Novel heterocyclic compounds
ZA984795B (en) New thiazolidinedione oxazolidinedione and oxadiazolidinedione derivatives
ZA972973B (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
AU2231397A (en) Thiazolidine-2,4-dione derivatives
AU6291098A (en) Novel heterocyclic compounds
AU4167099A (en) Heterocyclic compounds as hypoglycemic agents
HUP0003710A3 (en) 2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl]propylmercapto}pyrimidin-4-ol-fumarate and pharmaceutical composition containing this compound
IL160144A0 (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
MXPA03001956A (es) La sal de clorhidrato de 5-[4-[2-(n-metil, -n-metil-n -(2-piridil) amino) etoxi] bencil] tiazolidin-2, 4-diona.
HU9802874D0 (en) Process for making 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithiocarbazinate
AUPO622597A0 (en) New heterocyclic compounds
PL354991A1 (en) Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
AU8440498A (en) 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives
AU5437398A (en) Improved hand-held container for predissolving detergent composition
AUPO527597A0 (en) Novel heterocyclic compounds